JZ

Jingjing Zhao

SP Signal Pharmaceuticals: 19 patents #8 of 207Top 4%
📍 San Diego, CA: #2,239 of 23,606 inventorsTop 10%
🗺 California: #30,698 of 386,348 inventorsTop 8%
Overall (All Time): #234,256 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
11590139 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more 2023-02-28
11292796 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2022-04-05
10940152 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more 2021-03-09
10683298 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2020-06-16
10646493 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more 2020-05-12
10398700 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja +3 more 2019-09-03
10167290 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2019-01-01
10149849 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja +3 more 2018-12-11
9771371 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2017-09-26
9737541 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Sogole Bahmanyar, Joshua Hansen, Dehua Huang, Robert Hubbard +11 more 2017-08-22
9512124 Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Sogole Bahmanyar, Joshua Hansen, Dehua Huang, Robert Hubbard +11 more 2016-12-06
9193692 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2015-11-24
9079900 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2015-07-14
8907087 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2014-12-09
8569494 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2013-10-29
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-07-23
8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Sogole Bahmanyar, R.J. Bates, Kate Blease, Andrew Antony Calabrese, Thomas Oran Daniel +22 more 2012-10-30
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2012-02-07